Brian Belt, JD

Tumor Immunology Lab
University of Rochester Medical Center, United States

Presentation(s):

• 38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy

  Thursday, March 23, 2023
  10:26 AM – 10:36 AM

  Disclosure information not submitted.

• 44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis

  Thursday, March 23, 2023
  11:26 AM – 11:36 AM

  Disclosure information not submitted.

• P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study

  Friday, March 24, 2023
  1:21 PM – 1:26 PM

  Disclosure information not submitted.

• P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma

  Friday, March 24, 2023
  3:16 PM – 3:21 PM

  Disclosure information not submitted.

• 46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma

  Saturday, March 25, 2023
  9:56 AM – 10:06 AM

  Disclosure information not submitted.